Cargando…

New biomarkers of Kawasaki disease identified by urine proteomic analysis

Kawasaki disease (KD) is an acute systemic vasculitis that mainly afflicts infants and young children. The symptoms of KD are similar to those of various febrile diseases. Here, we attempted to develop accurate diagnostic biomarkers of KD by performing urine proteomic analysis of samples from health...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hui‐Min, Du, Hong‐Wu, Cui, Jia‐Wen, Feng, De‐Qin, Du, Zhong‐Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356163/
https://www.ncbi.nlm.nih.gov/pubmed/30761252
http://dx.doi.org/10.1002/2211-5463.12563
_version_ 1783391465206972416
author Hu, Hui‐Min
Du, Hong‐Wu
Cui, Jia‐Wen
Feng, De‐Qin
Du, Zhong‐Dong
author_facet Hu, Hui‐Min
Du, Hong‐Wu
Cui, Jia‐Wen
Feng, De‐Qin
Du, Zhong‐Dong
author_sort Hu, Hui‐Min
collection PubMed
description Kawasaki disease (KD) is an acute systemic vasculitis that mainly afflicts infants and young children. The symptoms of KD are similar to those of various febrile diseases. Here, we attempted to develop accurate diagnostic biomarkers of KD by performing urine proteomic analysis of samples from healthy controls, patients with KD, and patients with another febrile disease, pneumonia (two patients). We identified differentially expressed proteins (DEPs) in KD as compared to normal controls. We also constructed functional annotation and protein–protein interaction (PPI) networks of DEPs in KD and pneumonia. DEPs common to both KD and pneumonia were identified, as well as DEPs specific to KD. Compared to normal control, 43 and 62 DEPs were identified in KD and pneumonia, respectively. Serine hydroxymethyltransferase 1 is a hub protein of the KD‐specific PPI network. Thirteen DEPs common to both KD and pneumonia and 30 DEPs specific to KD were identified. Of these, the expression of eight DEPs could cluster normal and pneumonia samples into one group and cluster KD samples into another group based on hierarchical clustering. Our study identified several DEPs that may play a role in KD and that may serve as diagnostic biomarkers to distinguish patients with KD from both normal control and other febrile diseases.
format Online
Article
Text
id pubmed-6356163
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63561632019-02-13 New biomarkers of Kawasaki disease identified by urine proteomic analysis Hu, Hui‐Min Du, Hong‐Wu Cui, Jia‐Wen Feng, De‐Qin Du, Zhong‐Dong FEBS Open Bio Research Articles Kawasaki disease (KD) is an acute systemic vasculitis that mainly afflicts infants and young children. The symptoms of KD are similar to those of various febrile diseases. Here, we attempted to develop accurate diagnostic biomarkers of KD by performing urine proteomic analysis of samples from healthy controls, patients with KD, and patients with another febrile disease, pneumonia (two patients). We identified differentially expressed proteins (DEPs) in KD as compared to normal controls. We also constructed functional annotation and protein–protein interaction (PPI) networks of DEPs in KD and pneumonia. DEPs common to both KD and pneumonia were identified, as well as DEPs specific to KD. Compared to normal control, 43 and 62 DEPs were identified in KD and pneumonia, respectively. Serine hydroxymethyltransferase 1 is a hub protein of the KD‐specific PPI network. Thirteen DEPs common to both KD and pneumonia and 30 DEPs specific to KD were identified. Of these, the expression of eight DEPs could cluster normal and pneumonia samples into one group and cluster KD samples into another group based on hierarchical clustering. Our study identified several DEPs that may play a role in KD and that may serve as diagnostic biomarkers to distinguish patients with KD from both normal control and other febrile diseases. John Wiley and Sons Inc. 2018-12-20 /pmc/articles/PMC6356163/ /pubmed/30761252 http://dx.doi.org/10.1002/2211-5463.12563 Text en © 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Hu, Hui‐Min
Du, Hong‐Wu
Cui, Jia‐Wen
Feng, De‐Qin
Du, Zhong‐Dong
New biomarkers of Kawasaki disease identified by urine proteomic analysis
title New biomarkers of Kawasaki disease identified by urine proteomic analysis
title_full New biomarkers of Kawasaki disease identified by urine proteomic analysis
title_fullStr New biomarkers of Kawasaki disease identified by urine proteomic analysis
title_full_unstemmed New biomarkers of Kawasaki disease identified by urine proteomic analysis
title_short New biomarkers of Kawasaki disease identified by urine proteomic analysis
title_sort new biomarkers of kawasaki disease identified by urine proteomic analysis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356163/
https://www.ncbi.nlm.nih.gov/pubmed/30761252
http://dx.doi.org/10.1002/2211-5463.12563
work_keys_str_mv AT huhuimin newbiomarkersofkawasakidiseaseidentifiedbyurineproteomicanalysis
AT duhongwu newbiomarkersofkawasakidiseaseidentifiedbyurineproteomicanalysis
AT cuijiawen newbiomarkersofkawasakidiseaseidentifiedbyurineproteomicanalysis
AT fengdeqin newbiomarkersofkawasakidiseaseidentifiedbyurineproteomicanalysis
AT duzhongdong newbiomarkersofkawasakidiseaseidentifiedbyurineproteomicanalysis